Tuesday, November 5, 2019

Sun Pharma inks licensing pact with AstraZeneca to introduce products in China

Sun Pharma inks licensing pact with AstraZeneca to introduce products in China This comes after AstraZeneca said it was launching a new fund with China International Capital Corp to invest $1 billion in China#39;s healthcare sector, as it expands its research work in the country.

from Moneycontrol Business News https://ift.tt/32mmuQ3
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...